• SEQSTER and PatientsLikeMe Partner for Connected Patient Hub With Real-Time EHR Data

    Clinical Research News | SEQSTER and United Healthcare Group’s PatientsLikeMe (PLM) announced their strategic partnership to accelerate the patient screening process, improve the patient onboarding experience to increase retention and engagement, and provide more resources and tools for condition-specific communities.

    Sep 5, 2024

  • Quality of Life Measures to Become Commonplace in Cancer Clinical Trials

    Clinical Research News | A first-ever nationwide clinical trial examining the health-related quality of life (QoL) trajectory of young Hodgkin lymphoma patients undergoing treatment is “on the cusp of a new wave of measurement that is far more accessible and interpretable” for cancer patients and their physicians than clinical measures like number of relapses and overall survival.

    Sep 3, 2024

  • Follow the Money: Oncology, Autoimmunity, Breast, Prostate Clinical Trials, T Cell Products, More

    Clinical Research News | Third Arc Bio plan to advance through clinical studies to address significant unmet needs in oncology and autoimmunity; Halda Therapeutics are looking to advance two RIPTAC candidates into clinical trials for patients with prostate cancer and breast cancer; Outpace Bio will advance multiple programmed T cell product candidates to early clinical proof-of-concept for the treatment of solid tumors; and more.

    Aug 29, 2024

  • Easing Pancreatic Cancer Clinical Trials, Training the Scientists of Tomorrow, More

    Clinical Research News | myTomorrows and Pancreatic Cancer Europe have announced a new partnership to equip patients, caregivers, and healthcare professionals with up-to-date, accessible information about pre-approval treatments that may be relevant to them; the National Institutes of Health has awarded the Ohio State University a $4.38 million grant to support newly trained clinician-scientists for careers in medical research; and more.

    Aug 28, 2024

  • Walgreens and BARDA Enter Partnership to Progress Decentralized Clinical Research Program

    Clinical Research News | On Monday last week, Walgreens and the Biomedical Advanced Research and Development Authority (BARDA), a part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), announced a strategic partnership to further the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program.

    Aug 27, 2024

  • Fighting the Next Emerging Viral Outbreak: Key Ways to Improve Vaccine Access in Low-to-Middle-Income Countries

    Clinical Research News | n a post-pandemic environment, we know the emergence of another viral risk is inevitable. As such, the broader healthcare ecosystem has evaluated insights from drug development efforts in recent years to develop a shared focus on improving vaccine readiness and equitable access by populations of low-to-middle income countries, or “LMICs.”

    Aug 23, 2024

  • NIH Launches Native Collective Research Effort Focused on Overdose

    Clinical Research News | Last week, the National Institutes of Health (NIH) has launched the Native Collective Research Effort to Enhance Wellness (N CREW) Program, an effort support Native American communities to lead public health research to address overdose, substance use, and pain, including related factors such as mental health and wellness. The planned program funding totals approximately $268 million over seven years.

    Aug 20, 2024

  • PCORI Announces $165 Million In Funding For New Health Research

    Clinical Research News | The Patient-Centered Outcomes Research Institute (PCORI) has approved funding awards totaling more than $165 million for new patient-centered comparative clinical effectiveness research (CER), as well as research to improve methods and strengthen the science of engagement in patient-centered CER.

    Aug 15, 2024

  • First Clinical Trial of ‘Paradoxical Intervention’ for Cancer to Begin Soon

    Clinical Research News | Cancer cells are “not like superheroes that have no vulnerabilities.” Most current therapies try to block the signaling to prevent cancer’s uncontrolled division, but inevitably tumor cells resist the blockage and become far less responsive to subsequent therapy.

    Aug 14, 2024

  • Follow Five Best-in-Class Technology Practices for Improved Data Management Outcomes

    Clinical Research News | In today's data-driven world, clinical trials rely heavily on effective data management to ensure the accuracy and integrity of research findings. Improved data management outcomes ultimately benefit the primary beneficiary—the patient.

    Aug 13, 2024

  • Policy Change Alone Won’t Achieve Equity in Clinical Trial Participation

    Clinical Research News | A federal mandate that all state Medicaid programs cover the routine costs of participation in clinical trials could have a “meaningful impact” on equity in study participation. The focus should now be on ensuring states collaborate with frontline clinicians to ensure they are aware of the latest Medicaid policy change, and that those who “disproportionately treat patients from minoritized communities are plugged into relevant trial networks and able to refer patients to [applicable] trials.”

    Aug 8, 2024